XML 32 R20.htm IDEA: XBRL DOCUMENT v3.23.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2023
Summary of Significant Accounting Policies  
Schedule of anti-dilutive common stock equivalents excluded from the calculation of diluted net loss per share

The following common stock equivalents, including Series X Preferred Stock shown as common stock equivalents, were excluded from the calculation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect:

Three and Six Months Ended June 30,

    

2023

    

2022

Series X Preferred Stock

5,184,591

5,242,501

Stock options

 

3,183,045

 

2,106,150

Common stock warrants

 

331,858

 

1,530,176

8,699,494

8,878,827

Schedule of cash equivalents and restricted cash

The reconciliation of cash, cash equivalents and restricted cash reported within the applicable condensed consolidated balance sheet that sum to the total of the same such amount shown in the condensed consolidated statement of cash flows is as follows (in thousands):

June 30, 

    

2023

    

2022

Cash and cash equivalents

$

133,958

$

29,826

Restricted cash

163

284

Total

$

134,121

$

30,110